Simcere Pharmaceutical Group
Healthcare · Pharmaceutical Preparations · E9 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Clinical trials
ClinicalTrials.gov · ongoing · next readout first- Phase 1Not Yet Recruitingreadout ~2026-05-31A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults
- Phase 2Recruitingreadout ~2026-12-30Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients
- Phase 3Recruitingreadout ~2027-02-28SIM0718 Treatment of Asthma Clinical Study
- Phase 3Recruitingreadout ~2027-03-31A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
- Phase 2Not Yet Recruitingreadout ~2028-03-31A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis
Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
Recent SEC filings
All filings ↗- 15-12B15-12GJan 3, 2014
- EFFECTDec 30, 2013
- EFFECTDec 30, 2013
- POS AMF-3/ADec 24, 2013
- POS AMF-3/ADec 24, 2013
- S-8 POSDec 24, 2013
- 25-NSEDec 24, 2013
- SC 13D/ADec 24, 2013
- SC 13D/ADec 24, 2013
- SC 13D/ADec 24, 2013
- SC 13E3/ADec 24, 2013
- 6-KDec 23, 2013
- 6-KDec 19, 2013
- 6-KNov 19, 2013
- CORRESPNov 19, 2013